NKGen Biotech, Inc. Warrants
NKGNW
NKGNW was delisted on the 4th of March, 2025.
37 hedge funds and large institutions have $397K invested in NKGen Biotech, Inc. Warrants in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 1 closing their positions.
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
3% less funds holding
Funds holding: 38 → 37 (-1)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
72% less capital invested
Capital invested by funds: $1.43M → $397K (-$1.03M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ETH
Exos TFP Holdings
New York
|
+$2.65K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$2.16K |
| 3 |
FTUS
Flow Traders U.S.
New York
|
+$1.63K |
| 4 |
Walleye Capital
New York
|
+$455 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SG
StoneX Group
New York
|
-$3.73K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$619 |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$514 |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
-$407 |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$333 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $3K | – | – | – |
|
|
BI
27
Bulldog Investors
Saddle Brook,
New Jersey
| $2.8K | – | – | – |
|
|
SC
28
Sculptor Capital
New York
| $2.8K | -$100 | -700 | -4% |
|
|
29
Walleye Capital
New York
| $2.42K | +$455 | +3,200 | +23% |
|
|
GCIA
30
Gabelli & Co Investment Advisers
Rye,
New York
| $2.42K | – | – | – |
|
|
GF
31
Gabelli Funds
Rye,
New York
| $2.41K | -$407 | -2,858 | -14% |
|
|
SG
32
StoneX Group
New York
| $2.07K | -$3.73K | -26,229 | -64% |
|
|
33
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $2K | -$619 | -4,353 | -23% |
|
|
FTUS
34
Flow Traders U.S.
New York
| $2K | +$1.63K | +11,432 | New |
|
|
SIA
35
Schechter Investment Advisors
Birmingham,
Michigan
| $1.58K | – | – | – |
|
|
PI
36
PEAK6 Investments
Chicago,
Illinois
| $1.55K | – | – | – |
|
|
CCM
37
CAAS Capital Management
New York
| $1.4K | – | – | – |
|
|
CS
38
Clear Street
New York
| $45 | – | – | – |
|
NKGNW Hedge Fund Activity: Q1 2023 in Review
37 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q1 2023, worth a combined $397K — down 72% from $1.43M a quarter earlier.
Fund positioning in NKGNW was balanced in Q1 2023: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 6 trimmed.
The largest buyer was Exos TFP Holdings, adding an estimated $2.65K. The largest seller was StoneX Group, cutting an estimated $3.73K.
- 37 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q1 2023, down from 38 in Q4 2022.
- Funds reported $397K of NKGen Biotech, Inc. Warrants stock for Q1 2023, down 72% quarter-over-quarter.
- 1 fund opened new NKGen Biotech, Inc. Warrants positions in Q1 2023 and 1 closed out, a net change of 0 holders.
- The largest NKGen Biotech, Inc. Warrants buyer in Q1 2023 was Exos TFP Holdings, an estimated $2.65K added.
- The largest NKGen Biotech, Inc. Warrants seller in Q1 2023 was StoneX Group, an estimated $3.73K sold.
Based on aggregated 13F filings for Q1 2023.